Spontaneous rupture of the spleen on plasma cell leukemia.

per Stephens, P. J., Hudson, P.
Publicat 1969

TEAR GLUCOSE IN DIABETICS

per Lewis, J. G., Stephens, P. J.
Publicat 1958

Nickel-deficient carbon monoxide dehydrogenase from Rhodospirillum rubrum: in vivo and in vitro activation by exogenous nickel.

per Bonam, D, McKenna, M C, Stephens, P J, Ludden, P W
Publicat 1988

Site-directed mutagenesis of Azotobacter vinelandii ferredoxin I: cysteine ligation of the [4Fe-4S] cluster with protein rearrangement is preferred over serine ligation.

per Shen, B, Jollie, D R, Diller, T C, Stout, C D, Stephens, P J, Burgess, B K
Publicat 1995

Spectroscopic studies of ferricyanide oxidation of Azotobacter vinelandii ferredoxin I.

per Morgan, T V, Stephens, P J, Devlin, F, Stout, C D, Melis, K A, Burgess, B K
Publicat 1984

Cluster characterization in iron-sulfur proteins by magnetic circular dichroism.

per Stephens, P J, Thomson, A J, Keiderling, T A, Rawlings, J, Rao, K K, Hall, D O
Publicat 1978

Site-directed mutagenesis of Azotobacter vinelandii ferredoxin I: [Fe-S] cluster-driven protein rearrangement.

per Martín, A E, Burgess, B K, Stout, C D, Cash, V L, Dean, D R, Jensen, G M, Stephens, P J
Publicat 1990

Skeletal muscle morphology in sarcopenia defined using the EWGSOP criteria: findings from the Hertfordshire Sarcopenia Study (HSS)

per Patel, H. P., White, M. C., Westbury, L., Syddall, H. E., Stephens, P. J., Clough, G. F., Cooper, C., Sayer, A. A.
Publicat a BMC Geriatr (2015)

[4Fe-4S]-cluster-depleted Azotobacter vinelandii ferredoxin I: a new 3Fe iron-sulfur protein.

per Stephens, P J, Morgan, T V, Devlin, F, Penner-Hahn, J E, Hodgson, K O, Scott, R A, Stout, C D, Burgess, B K
Publicat 1985

Circular dichroism and magnetic circular dichroism of nitrogenase proteins

per Stephens, P. J., McKenna, C. E., Smith, B. E., Nguyen, H. T., McKenna, M-C., Thomson, A. J., Devlin, F., Jones, J. B.
Publicat 1979

On the structure of the nickel/iron/sulfur center of the carbon monoxide dehydrogenase from Rhodospirillum rubrum: an x-ray absorption spectroscopy study.

per Tan, G O, Ensign, S A, Ciurli, S, Scott, M J, Hedman, B, Holm, R H, Ludden, P W, Korszun, Z R, Stephens, P J, Hodgson, K O
Publicat 1992

Next-generation sequencing reveals frequent consistent genomic alterations in small cell undifferentiated lung cancer

per Ross, J S, Wang, K, Elkadi, O R, Tarasen, A, Foulke, L, Sheehan, C E, Otto, G A, Palmer, G, Yelensky, R, Lipson, D, Chmielecki, J, Ali, S M, Elvin, J, Morosini, D, Miller, V A, Stephens, P J
Publicat 2014

Inhibiting MEK in MAPK pathway-activated myeloma

per Heuck, C J, Jethava, Y, Khan, R, van Rhee, F, Zangari, M, Chavan, S, Robbins, K, Miller, S E, Matin, A, Mohan, M, Ali, S M, Stephens, P J, Ross, J S, Miller, V A, Davies, F, Barlogie, B, Morgan, G
Publicat a Leukemia (2016)

Loss of function of NF1 is a mechanism of acquired resistance to endocrine therapy in lobular breast cancer

per Sokol, E S, Feng, Y X, Jin, D X, Basudan, A, Lee, A V, Atkinson, J M, Chen, J, Stephens, P J, Frampton, G M, Gupta, P B, Ross, J S, Chung, J H, Oesterreich, S, Ali, S M, Hartmaier, R J
Publicat a Ann Oncol (2019)

Comprehensive genomic profiles of metastatic and relapsed salivary gland carcinomas are associated with tumor type and reveal new routes to targeted therapies

per Ross, J. S., Gay, L. M., Wang, K., Vergilio, J.-A., Suh, J., Ramkissoon, S., Somerset, H., Johnson, J. M., Russell, J., Ali, S., Schrock, A. B., Fabrizio, D., Frampton, G., Miller, V., Stephens, P. J., Elvin, J. A., Bowles, D. W.
Publicat a Ann Oncol (2017)

Comprehensive genomic profiling identifies a novel TNKS2–PDGFRA fusion that defines a myeloid neoplasm with eosinophilia that responded dramatically to imatinib therapy

per Chalmers, Z R, Ali, S M, Ohgami, R S, Campregher, P V, Frampton, G M, Yelensky, R, Elvin, J A, Palma, N A, Erlich, R, Vergilio, J-A, Chmielecki, J, Ross, J S, Stephens, P J, Hermann, R, Miller, V A, Miles, C R
Publicat a Blood Cancer J (2015)

Next-generation sequencing of adrenocortical carcinoma reveals new routes to targeted therapies

per Ross, J S, Wang, K, Rand, J V, Gay, L, Presta, M J, Sheehan, C E, Ali, S M, Elvin, J A, Labrecque, E, Hiemstra, C, Buell, J, Otto, G A, Yelensky, R, Lipson, D, Morosini, D, Chmielecki, J, Miller, V A, Stephens, P J
Publicat 2014

Genomic alterations in head and neck squamous cell carcinoma determined by cancer gene-targeted sequencing

per Chung, C. H., Guthrie, V. B., Masica, D. L., Tokheim, C., Kang, H., Richmon, J., Agrawal, N., Fakhry, C., Quon, H., Subramaniam, R. M., Zuo, Z., Seiwert, T., Chalmers, Z. R., Frampton, G. M., Ali, S. M., Yelensky, R., Stephens, P. J., Miller, V. A., Karchin, R., Bishop, J. A.
Publicat a Ann Oncol (2015)

Oncogenic and drug sensitive NTRK1 rearrangements in lung cancer

per Vaishnavi, A., Capelletti, M., Le, A.T., Kako, S., Butaney, M., Ercan, D., Mahale, S., Davies, K.D., Aisner, D.L., Pilling, A.B., Berge, E.M., Kim, J., Sasaki, H., Park, S., Kryukov, G., Garraway, L.A., Hammerman, Peter S., Haas, J., Andrews, S.W., Lipson, D., Stephens, P.J., Miller, V.A., Varella-Garcia, M., Jänne, P.A., Doebele, R.C.
Publicat 2013

Hybrid capture-based genomic profiling of circulating tumor DNA from patients with estrogen receptor-positive metastatic breast cancer

per Chung, J H, Pavlick, D, Hartmaier, R, Schrock, A B, Young, L, Forcier, B, Ye, P, Levin, M K, Goldberg, M, Burris, H, Gay, L M, Hoffman, A D, Stephens, P J, Frampton, G M, Lipson, D M, Nguyen, D M, Ganesan, S, Park, B H, Vahdat, L T, Leyland-Jones, B, Mughal, T I, Pusztai, L, O’Shaughnessy, J, Miller, V A, Ross, J S, Ali, S M
Publicat a Ann Oncol (2017)